Product Categories
| Country: | China |
|---|---|
| Tel: | 021-65675885 |
| Mobile: | 18964387627 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| SR4554 | C8H9F3N4O4 | 167648-73-9 | Details |
| Sulesomab | 167747-19-5 | Details |
| Felvizumab | 167747-20-8 | Details |
| GNE-0946 | C22H12ClF3N2O4 | 1677667-24-1 | Details |
| Faralimomab | 167816-91-3 | Details |
| (R)-VX-11e | C24H20Cl2FN5O2 | 1680187-43-2 | Details |
| DJ4 | C19H16N4OS | 1681020-24-5 | Details |
| PG 34 | C28H25N3O5S2 | 1681056-62-1 | Details |
| Propofol-d17 β-D glucuronide | C18H26O7 | 1683581-05-6 | Details |
| Rosmantuzumab | 1684393-04-1 | Details |
| YM-58790 | C27H31N3O2 | 168830-70-4 | Details |
| αvβ1 integrin-IN-1 | C26H34N6O6S | 1689540-62-2 | Details |
| Flupyrimin | C13H9ClF3N3O | 1689566-03-7 | Details |
| Obexelimab | 1690307-05-1 | Details |
| Lanepitant | C33H45N5O3 | 170566-84-4 | Details |
| ARTD10/PARP10-IN-1 | C12H12N2O4 | 1708103-76-7 | Details |
| 1-vinylpyrene | C18H12 | 17088-21-0 | Details |
| Frunevetmab | 1708936-80-4 | Details |
| Emapalumab | 1709815-23-5 | Details |
| Igovomab | 171656-50-1 | Details |
| Piprozolin | C14H22N2O3S | 17243-64-0 | Details |
| tert-Butyl (6-iodohexyl)carbamate | C11H22INO2 | 172846-36-5 | Details |
| Inophyllum E | C25H22O5 | 17312-31-1 | Details |
| (E)-3-(2-Chloro-4-fluorophenyl)acrylic acid | C9H6ClFO2 | 174603-37-3 | Details |
| Keliximab | 174722-30-6 | Details |
| Tidembersat | C20H19F2NO4 | 175013-73-7 | Details |
| BODIPY FL prazosin | 175799-93-6 | Details |
| Tagatose | C6H12O6 | 17598-81-1 | Details |
| Izonsteride | C24H26N2OS2 | 176975-26-1 | Details |
| 3,4,5-Trihydroxycinnamic acid decyl ester | C19H28O5 | 1770778-45-4 | Details |
| MMP2-IN-2 | C13H8N4O4 | 1772-39-0 | Details |
| Phenmedipham-d3 | C16H16N2O4 | 1773497-41-8 | Details |
| Sarizotan 2HCl | C22H22ClFN2O | 177976-12-4 | Details |
| Opaviraline | C14H17FN2O3 | 178040-94-3 | Details |
| Telisotuzumab | 1781223-80-0 | Details |
| BMS-599626 2HCL(714971-09-2 Free base) | C27H28ClFN8O3 | 1781932-33-9 | Details |
| RKI-1447 dihydrochloride | C16H15ClN4O2S | 1782109-09-4 | Details |
| ML 120B dihydrochloride | C19H16Cl2N4O2 | 1782573-78-7 | Details |
| Xanthine amine congener hydrochloride | C21H29ClN6O4 | 1783977-95-6 | Details |
| LDN-209929 dihydrochloride | C17H18Cl2N2OS | 1784281-97-5 | Details |
| FK 866 hydrochloride (658084-64-1 free base) | C24H30ClN3O2 | 1785666-54-7 | Details |
| NLRP3/AIM2-IN-3 | C16H14N2O2 | 1787787-60-3 | Details |
| Gosuranemab | 1788032-39-2 | Details |
| UC-781 | C17H18ClNO2S | 178870-32-1 | Details |
| Nav1.7-IN-3 | C17H20ClFN4O2S2 | 1788872-06-9 | Details |
| Basiliximab | 179045-86-4 | Details |
| WAY-639228 | C22H24N2O2S | 179051-05-9 | Details |
| Remtolumab | 1791410-27-9 | Details |
| Lutikizumab | 1791411-57-8 | Details |
| Elezanumab | 1791416-49-3 | Details |
| Dilpacimab | 1791420-09-1 | Details |
| (2R,5S)-Ritlecitinib | C15H19N5O | 1792180-79-0 | Details |
| Vunakizumab | 1792181-33-9 | Details |
| SB-237376 | C20H25N3O5 | 179258-59-4 | Details |
| Porgaviximab | 1792982-55-8 | Details |
| Crizanlizumab | 1690318-25-2 | Details |
| DP00477 | C17H11ClF3N3OS | 169120-56-3 | Details |
| SXC 2023 | C13H15NO4S | 1695562-36-7 | Details |
| Nonabine | C25H33NO2 | 16985-03-8 | Details |
| Anisperimus | C18H39N7O3 | 170368-04-4 | Details |
| Cevidoplenib | C25H27N7O3 | 1703788-21-9 | Details |
| NLRP3-IN-13 | C19H15N3O3S | 1704638-35-6 | Details |
| AZ-PFKFB3-67 | C26H25N5O3 | 1704741-11-6 | Details |
| Lanepitant 2HCl | C33H46ClN5O3 | 170508-05-1 | Details |
| Larcaviximab | 1792982-56-9 | Details |
| Cosfroviximab | 1792982-57-0 | Details |
| ER-34122 | C27H26ClN3O5 | 179325-62-3 | Details |
| Sacituzumab | 1796566-95-4 | Details |
| Netakimab | 1796570-08-5 | Details |
| PF-04822163 | C19H17ClN2O2 | 1798334-07-2 | Details |
| GPR40 agonist 6 | C20H19NO4 | 1798751-25-3 | Details |
| GNF6702 | C22H16FN7O2 | 1799329-72-8 | Details |
| GSK180 | C10H7Cl2NO4 | 1799725-26-0 | Details |
| BCAT-IN-2 | C17H14ClF2N5O | 1800024-45-6 | Details |
| Oleoylestrone | C36H54O3 | 180003-17-2 | Details |
| Vutiglabridin | C22H26O4 | 1800188-47-9 | Details |
| Gremubamab | 1800381-36-5 | Details |
| SR12418 | C31H30FNO3 | 1801185-08-9 | Details |
| Odronextamab | 1801338-64-6 | Details |
| Cemiplimab | 1801342-60-8 | Details |
| RYL-552 | C24H17F4NO2 | 1801444-56-3 | Details |
| Losatuxizumab | 1801544-27-3 | Details |
| KL044 | C21H14ClN3O | 1801856-93-8 | Details |
| Minzasolmin | C23H31N5OS | 1802518-92-8 | Details |
| ZY-444 | C26H28N4OS | 1802650-31-2 | Details |
| ABBV-318 | C20H15F4N3O2 | 1802848-94-7 | Details |
| RN-1665 | C20H24F5N3O3S2 | 1803003-65-7 | Details |
| Ravulizumab | 1803171-55-2 | Details |
| Oleclumab | 1803176-05-7 | Details |
| NDH-1 inhibitor-1 | C20H19NO3 | 173964-49-3 | Details |
| Sodium zirconium cyclosilicate | 17141-74-1 | Details |
| Cynandione A | C16H14O6 | 168706-29-4 | Details |
| Dyrk1A-IN-5 | C16H9IN2O2 | 1685235-41-9 | Details |
| RYL-552S | C24H17F4NOS | 1801444-69-8 | Details |
| Thalidomide-O-amido-CH2-PEG3-CH2-NH-Boc | C30H42N4O11 | 1799711-31-1 | Details |
| CCT245232 | C27H23N3O4 | 1693731-14-4 | Details |
| SB-237376 HCl | C20H26ClN3O5 | 179258-62-9 | Details |
| CYP1B1-IN-5 | C14H8INO2 | 176442-56-1 | Details |
| Roxifiban acetate | C23H33N5O8 | 176022-59-6 | Details |
| ATX-002 | C39H72N2O5S | 1777792-34-3 | Details |
| Product Total： Product Page： | ||||
| 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 | ||||